Antag Therapeutics ApS
38402056ActivePioneering novel GIP receptor antagonist therapies for treating chronic obesity.
Overview
- 7
- Employees
- Unknown
- Revenue
- 2017
- Founded
Key Decision Makers
Jens Juul Holst
Founder and Professor
Philip Just Larsen
Chief Executive Officer
Mette Rosenkilde
Founder and Professor
Description
Antag Therapeutics is a clinical-stage biopharmaceutical company based in Copenhagen, Denmark, dedicated to redefining the treatment of obesity and metabolic disorders. The company focuses on pioneering a novel class of therapies through GIP receptor antagonism to address the limitations of current...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- APS
- VAT Number
- DK38402056
Decision Makers
3 contacts in FunnelfeedrJens Juul Holst
Founder and Professor
Philip Just Larsen
Chief Executive Officer
Mette Rosenkilde
Founder and Professor
Similar Companies
20 similar companies in FunnelfeedrAlveus Therapeutics ApS
12 employeesClinical-stage biotech developing next-generation therapies for obesity and metabolic diseases.
ZEALAND PHARMA A/S
520 employeesInnovative biotechnology company developing peptide-based medicines for metabolic health.
ASCENDIS PHARMA A/S
629 employeesGlobal biopharmaceutical company developing innovative therapies using proprietary TransCon technology.
Pephexia Therapeutics ApS
5 employeesDeveloping innovative peptide-based therapies for treating cachexia and sarcopenia.
ZEALAND PHARMA A/S
0 employeesDeveloping peptide medicines for metabolic health challenges globally.
Browse More
Antag Therapeutics ApS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo